Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis

Pharmacological Reports

Volumn 64, Issue 3, 2012, Pages 615-624

  Setia, Shruti ^a   Sanyal, Sankar N ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

COX; DMBA; Etoricoxib; Indomethacin; Mitochondrial apoptotic pathway

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 9; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HYPERPLASIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84866064036     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70857-5     Document Type: Article

References (37)

1. Albayrak A, Polat B, Cadirci E, Hacimuftuoglu A, Halici Z, Gulapoglu M, Albayrak F, Suleyman H: Gastric anti-ulcerative and anti-inflammatory activity of metyrosine in rats. Pharmacol Rep, 2010, 62, 113-119.
2. Cossarizza A, Salvioli S: Flow cytometric analysis of mitochondrial membrane potential using JC-1. Curr Protoc Cytom, 2001, Chapter 9, Unit 9.14.
3. Dejean LM, Caballero SM, Kinnally KW: Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis? Cell Death Differ, 2006, 13, 1387-1405.
4. Douglas G: Means to an end. Cold Spring Harbor Laboratory Press, New York, 2011.
5. Fadeel B, Orrenius S: Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med, 2005, 258, 479-551.
6. Fesik SW: Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer, 2005, 5, 876-885.
7. Fischer U, Schulze-Osthoff K: New approaches and therapeutics targeting apoptosis in disease. Pharmacol Rev, 2005, 57, 187-215.
8. Ghosh N, Chaki R, Mandal V, Mandal SC: COX-2 as a target for cancer chemotherapy. Pharmacol Rep, 2010, 62, 233-244.
9. Harris RE, Beebe-Donk J, Alshafie GA: Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study. Int J Biol Sci, 2007, 3, 328-334.
10. Harris RE, Beebe-Donk J, Schuller HM: Chemoprevention of lung cancer by NSAIDs among cigarette smokers. Oncol Rep, 2002, 9, 693-615.
11. Haynes A, Shaik MS, Chatterjee A, Singh M: Evaluation of an aerosolized selective COX-2 inhibitor as a potentiator of doxorubicin in a non-small-cell lung cancer cell line. Pharm Res, 2003, 20, 1485-1495.
12. Kaur J, Sanyal SN: Oxidative stress and stress-signaling in chemoprevention of early colon cancer by diclofenac. Am J Biomed Sci, 2010, 2, 63-78.
13. Keith A, Alexander J, Julian L, Roberts MR, Peter W: Apoptosis: programmed cell death eliminates unwanted cells. In: Molecular Biology of the Cell. Ed. Anderson M, Granum S, Garland Science, New York, 2008, 1115.
14. Krysan K, Reckamp KL, Sharma S, Dubinett SM: The potential and rationale for COX-2 inhibitors in lung cancer. Anticancer Agents Med Chem, 2006, 6, 209-220.
15. Kwiecińska P, Wróbel A, Gregoraszczuk EŁ. Combinatory effects of PBDEs and 17β-estradiol on MCF-7 cell proliferation and apoptosis. Pharmacol Rep, 2011, 63, 189-194.
16. Lambrecht BN: Alveolar macrophage in the driver's seat. Immunity, 2006, 24, 366-368.
17. Li N, Chen X, Liao J, Yang G, Wang S, Josephson Y, Chi H: Inhibition of 7,12-dimethylbenz(a)anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis, 2003, 23, 1307-1313.
18. Lowe SW, Cepero E, Evan G: Intrinsic tumour suppression. Nature, 2004, 432, 307-315.
19. Mittal N, Sanyal SN: Inflammatory response of lung derived cells in rat pups following intratracheal surfactant instillation. Am J Biomed Sci, 2010, 2, 239-247.
20. Pearse AGE: Histochemistry, theoretical and applied. 3rd edn., Churchill Livingstone, London, 1968, 660.
21. Proost ID, Pintelon I, Brouns I, Kroese ABA, Riccardi D, Kemp PJ, Timmermans JP et al.: Functional live cell imaging of the pulmonary neuroepithelial body microenvironment. Am J Respir Cell Mol Biol, 2008, 39, 180-189.
22. Reed JC: Drug insight: Cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol, 2006, 3, 388-398.
23. Reinacher-Schick A, Schoeneck A, Graeven U, Schwarte-Waldhoff I, Schmiegel W: Mesalazine causes a mitotic arrest and induces caspase dependent apoptosis in colon carcinoma cells. Carcinogenesis, 2003, 24, 443-451.
24. Riendeau D, Percival MD, Brideau C, Charleson S, Dube D, Ethier D, Falguryret JP: Etoricoxib (MK-0663): Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther, 2001, 296, 558-566.
25. Saini RK, Sanyal SN: Pulmonary carcinogenesis in mice with a single intratracheal instillation of 9,10-dimethyl benz(a)anthracene. Drug Chem Toxicol, 2008, 31, 459-471.
26. Seo SK, Lee HC, Woo SH, Jin HO, Yoo DH, Lee SJ, An S: Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase induced mitochondrial dysfunction. Apoptosis, 2007, 12, 195-209.
27. Sodini D, Baragatti B, Barogi S, Laubach VE, Coceani F: Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse. Br J Pharmacol, 2008, 153, 1631-1640.
28. Subbaramaiah K, Dannenberg AJ: Cyclooxygenase 2: A molecular target for cancer prevention and treatment. Trends Pharmacol Sci, 2003, 24, 96-102.
29. Susin SA, Zamzami N, Kroemer G: The cell biology of apoptosis: Evidence for the implication of mitochondria. Apoptosis, 1996, 1, 231-242.
30. Suzuki JS, Nishimura N, Zhang B, Nakatsuru Y, Kobayashi S, Satoh M, Tohyama C: Metallothionin deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionin-null mice. Carcinogenesis, 2003, 24, 1123-1132.
31. Takabayshi K, Corr M, Hayashi T, Redecke V, Beck L, Guiney D, Sheppard D, Raz E: Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity, 2006, 24, 475-487.
32. Thakur P, Sanyal SN: Chemopreventive action of diclofenac in dimethylbenzanthracene induced lung cancer in female wistar rat. J Environ Pathol Toxicol Oncol, 2010, 29, 255-265.
33. Thakur P, Sanyal SN: Chemopreventive role of preferential COX-2 inhibitor diclofenac in 9,10- dimethylbenz(a)anthracene induced experimental lung carcinogenesis. Am J Biomed Sci, 2010, 2, 275-288.
34. Thakur P, Sanyal SN: Induction of pulmonary carcinogenesis in Wistar rats by a single dose of 9,10 dimethylbenz(a)anthracene (DMBA) and the chemopreventive role of diclofenac. Exp Mol Pathol, 2010, 88, 394-400.
35. Vaish V, Sanyal SN. Chemopreventive effects of NSAIDs on cytokines and transcription factors during the early stages of colorectal cancer. Pharmacol Rep, 2011, 63, 1210-1221.
36. Vaish V, Sanyal SN: Non-steroidal anti-inflammatory drugs modulate the physicochemical properties of plasma membrane in experimental colorectal cancer: A fluorescence spectroscopic study. Mol Cell Biochem, 2011, 358, 161-171.
37. Yuan Y, Zhi-Qiang GE, Jing-Chuan L: Differentiation of apoptotic and necrotic cells in suspension cultures of Taxus cuspidatea by the combined use of fluorescent dying and histochemical staining methods. Biotechnol Lett, 2002, 24, 71-76.